Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers.
作者信息
Staiger C, Korodnay B, Devries J X, Weber E, Müller P, Simon B, Dammann H G
出版信息
Br J Clin Pharmacol. 1984 Jul;18(1):105-6. doi: 10.1111/j.1365-2125.1984.tb05031.x.
Abstract
摘要
相似文献
1
Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers.法莫替丁和西咪替丁对健康志愿者安替比林代谢动力学的比较效应。
Br J Clin Pharmacol. 1984 Jul;18(1):105-6. doi: 10.1111/j.1365-2125.1984.tb05031.x.
2
[Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human].
Arzneimittelforschung. 1984;34(9):1041-2.
3
Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
Clin Ther. 1987;9(6):602-6.
4
Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers.法莫替丁和西咪替丁对正常志愿者体内茶碱药代动力学的比较效应。
Br J Clin Pharmacol. 1987 Nov;24(5):669-72. doi: 10.1111/j.1365-2125.1987.tb03228.x.
5
Comparative effects of H2-receptor antagonists on drug interaction in rats.H2受体拮抗剂对大鼠药物相互作用的比较效应。
Drug Metab Dispos. 1986 Nov-Dec;14(6):649-53.
6
Comparative effects of famotidine and cimetidine on trimethadione metabolism in the rat.
Biochem Pharmacol. 1986 Mar 1;35(5):869-71. doi: 10.1016/0006-2952(86)90258-3.
7
Cimetidine versus famotidine: the effect on the pharmacokinetics of theophylline in rats.西咪替丁与法莫替丁：对大鼠体内茶碱药代动力学的影响。
Eur J Drug Metab Pharmacokinet. 1985 Apr-Jun;10(2):155-9. doi: 10.1007/BF03189710.
8
Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.西咪替丁、雷尼替丁、法莫替丁及安慰剂对30名正常志愿者胃内酸度影响的双盲比较。
Gut. 1988 Jan;29(1):81-4. doi: 10.1136/gut.29.1.81.
9
The effect of famotidine, a new H2 receptor antagonist, on antipyrine clearance in healthy volunteers.
Pharmacol Res Commun. 1987 Feb;19(2):183-90. doi: 10.1016/0031-6989(87)90008-7.
10
Famotidine effects on theophylline pharmacokinetics in subjects affected by COPD. Comparison with cimetidine and placebo.
Chest. 1988 Oct;94(4):807-10. doi: 10.1378/chest.94.4.807.
引用本文的文献
1
Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series.法莫替丁在非住院 COVID-19 患者中的应用及定量症状跟踪：一项病例系列研究。
Gut. 2020 Sep;69(9):1592-1597. doi: 10.1136/gutjnl-2020-321852. Epub 2020 Jun 4.
2
Comparative effects of famotidine and cimetidine on 7-ethoxycoumarin O-deethylase activity in human livers.法莫替丁和西咪替丁对人肝脏中7-乙氧基香豆素O-脱乙基酶活性的比较作用。
Br J Clin Pharmacol. 1986 Oct;22(4):495-6. doi: 10.1111/j.1365-2125.1986.tb02925.x.
3
Newer H2-receptor antagonists. Clinical pharmacokinetics and drug interaction potential.新型H2受体拮抗剂。临床药代动力学及药物相互作用潜力。
Clin Pharmacokinet. 1988 Oct;15(4):205-15. doi: 10.2165/00003088-198815040-00001.
4
Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects.法莫替丁不影响健康受试者体内吲哚菁绿的代谢及血清胆汁酸水平。
Br J Clin Pharmacol. 1987 Jun;23(6):779-80.
5
Adverse reactions and interactions with H2-receptor antagonists.H2受体拮抗剂的不良反应及相互作用。
Med Toxicol. 1986 May-Jun;1(3):192-216. doi: 10.1007/BF03259837.
6
Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.法莫替丁。药效学和药代动力学特性及其在消化性溃疡疾病和佐林格-埃利森综合征治疗应用的初步综述。
Drugs. 1986 Sep;32(3):197-221. doi: 10.2165/00003495-198632030-00001.
7
Effect of famotidine on oxidative drug metabolism.法莫替丁对药物氧化代谢的影响。
Eur J Clin Pharmacol. 1986;30(3):279-81. doi: 10.1007/BF00541528.
8
Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.法莫替丁，一种新型H2受体拮抗剂，不影响地西泮的肝脏清除或普鲁卡因胺的肾小管分泌。
Eur J Clin Pharmacol. 1985;28(6):671-5. doi: 10.1007/BF00607913.
9
Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.法莫替丁。对其药效学和药代动力学特性以及在消化性溃疡疾病和其他相关疾病中的治疗用途的最新综述。
Drugs. 1989 Oct;38(4):551-90. doi: 10.2165/00003495-198938040-00005.
10
Randomized, double-blind comparison of famotidine with ranitidine in treatment of acute, benign gastric ulcer disease. Community-based study coupled with a patient registry.
Dig Dis Sci. 1989 Jul;34(7):1047-52. doi: 10.1007/BF01536372.
本文引用的文献
1
24 hour intragastric acidity and single night-time dose of three H-2-blockers.24小时胃内酸度及三种H-2受体阻滞剂的单次夜间剂量
Lancet. 1983 Nov 5;2(8358):1078. doi: 10.1016/s0140-6736(83)91057-7.
2
Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs.新型强效H2受体阻滞剂3-[[2-[(二氨基亚甲基)氨基]-4-噻唑基]甲基]-硫代]-N2-氨磺酰基丙脒（YM-11170）对清醒犬组胺和食物诱导的胃酸分泌的影响。
Arch Int Pharmacodyn Ther. 1982 Mar;256(1):49-58.
Zotero 插件